Date Filed | Type | Description |
07/20/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/05/2022 |
3
| Reddi Anand (Director) has filed a Form 3 on Hepion Pharmaceuticals, Inc. |
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Foster Robert T (CEO, CSO and Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Granted 1,900,000 options to buy
@ $1.7, valued at
$3.2M
|
|
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Block Timothy M. (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Granted 200,000 options to buy
@ $1.7, valued at
$340k
|
|
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/18/2021 |
4
| Wijngaard Peter (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Bought 10,000 shares
@ $2.2, valued at
$22k
|
|
02/18/2021 |
4
| Foster Robert T (CEO and Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Bought 20,000 shares
@ $2, valued at
$40k
|
|
02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/21/2020 |
4
| Wijngaard Peter (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Bought 20,000 shares
@ $1.91, valued at
$38.2k
|
|
12/08/2020 |
4
| Foster Robert T (CEO and Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Bought 25,000 shares
@ $1.5767, valued at
$39.4k
|
|
12/02/2020 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Bought 7,000 shares
@ $1.53, valued at
$10.7k
|
|
12/01/2020 |
4
| JACOB GARY S (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Bought 12,000 shares
@ $1.66, valued at
$19.9k
|
|
11/30/2020 |
4
| Cavan John T (CFO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Bought 4,500 shares
@ $1.62, valued at
$7.3k
|
|
08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/07/2020 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Granted 60,000 options
@ $1.63, valued at
$97.8k
|
|
04/07/2020 |
4
| Block Timothy M. (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Granted 60,000 options
@ $1.63, valued at
$97.8k
|
|
04/07/2020 |
4
| Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Granted 60,000 options
@ $1.63, valued at
$97.8k
|
|
04/07/2020 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Granted 60,000 options
@ $1.63, valued at
$97.8k
|
|
04/07/2020 |
4
| Foster Robert T (CEO and CSO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Granted 380,000 options
@ $1.63, valued at
$619.4k
|
|
04/07/2020 |
4
| JACOB GARY S (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns:
| Granted 60,000 options
@ $1.63, valued at
$97.8k
|
|
|